UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 92 filers reported holding UTAH MED PRODS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $495,876 | -6.9% | 5,766 | +0.9% | 0.00% | 0.0% |
| Q2 2023 | $532,452 | +6.8% | 5,713 | +8.6% | 0.00% | 0.0% |
| Q1 2023 | $498,680 | -10.4% | 5,262 | -5.0% | 0.00% | -33.3% |
| Q4 2022 | $556,635 | +17.9% | 5,537 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $472,000 | -0.8% | 5,537 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $476,000 | +43.8% | 5,537 | +50.1% | 0.00% | +100.0% |
| Q1 2022 | $331,000 | -10.3% | 3,688 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $369,000 | +7.9% | 3,688 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $342,000 | -2.8% | 3,688 | -10.9% | 0.00% | 0.0% |
| Q2 2021 | $352,000 | -1.7% | 4,138 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $358,000 | +44.4% | 4,138 | +40.4% | 0.00% | +100.0% |
| Q4 2020 | $248,000 | +5.5% | 2,947 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $235,000 | -0.4% | 2,947 | +10.6% | 0.00% | 0.0% |
| Q2 2020 | $236,000 | – | 2,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clean Yield Group | 49,094 | $3,535,000 | 1.48% |
| MORGAN DEMPSEY CAPITAL MANAGEMENT LLC | 27,464 | $1,988,000 | 0.72% |
| Ativo Capital Management LLC | 16,525 | $1,196,000 | 0.33% |
| Ancora Advisors LLC | 55,159 | $3,993,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 10,754 | $779,000 | 0.23% |
| Cardinal Capital Management | 9,180 | $665,000 | 0.22% |
| Acrospire Investment Management LLC | 1,919 | $139,000 | 0.13% |
| Penobscot Investment Management Company, Inc. | 4,000 | $290,000 | 0.09% |
| TFS CAPITAL LLC | 3,226 | $234,000 | 0.09% |
| WCM INVESTMENT MANAGEMENT, LLC | 81,912 | $5,930,000 | 0.09% |